PDCD1 and cancer: By contrast, this subset of aggressive CRCs is also associated with lower levels of PD-1-positive tumor infiltrating lymphocytes but high levels of PD-1-positive tumor infiltrating lymphocytes have been robustly associated with poor survival in many cancers [23,26,30–32].